Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC) Meeting Abstract
| Authors: | Mita, M. M.; Becerra, C.; Richards, D. A.; Mita, A. C.; Shagisultanova, E.; Osborne, C. R. C.; O'Shaughnessy, J.; Zhang, C.; Henner, R.; Kapoun, A. M.; Xu, L.; Dupont, J.; Brachmann, R. K.; Farooki, A.; Diamond, J. R. |
| Abstract Title: | Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 118s |
| Language: | English |
| ACCESSION: | WOS:000404665403115 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.2516 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2516 -- Source: Wos |
